NCT00706732 - A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

March 31, 2009

Conditions

Influenza

Interventions

BIOLOGICAL

AVX502

2 doses at 2e8 IU given at T=0 and T=4 weeks via the IM route

BIOLOGICAL

AVX502

2 doses at 2e8 IU given at T=0 and T=4 weeks given via the SC route

BIOLOGICAL

Placebo

2 doses of placebo given at T=0 and T=4 weeks via the IM route

BIOLOGICAL

Placebo

2 doses of placebo given at T=0 and T=4 weeks via the SC route

Trial Locations (1)

Johnson County Clin-Trials, Lenexa